EXSERA BIOLABS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 06 Dec 2023)
What this means for you
Registered since 13 Jun 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87088353
- Registration number
- 5224578
- Mark type
- Stylized text
- Filed
- 29 Jun 2016
- Published for opposition
- 29 Nov 2016
- Registered
- 13 Jun 2017
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical drug development services; Research and development in the field of reagent, assay, biomarker and clinical target development
- Class 044 — Medical, beauty and agricultural services: Medical testing for diagnostic or treatment purposes in the field of rheumatology, autoimmunity, complement and esoteric biomarkers
Owner
- The Regents of the University of Colorado, a body corporate, Denver, CO, US
- The Regents of the University of Colorado, a body corporate, Denver, CO, US
- The Regents of the University of Colorado, a body corporate, Denver, CO, US
Prosecution history
- 07 Dec 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 06 Dec 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 06 Dec 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 08 Jun 2023 — TEAS SECTION 8 & 15 RECEIVED
- 13 Jun 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 13 Jun 2017 — REGISTERED-PRINCIPAL REGISTER
- 12 May 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 May 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 Mar 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Mar 2017 — USE AMENDMENT FILED
- 24 Mar 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Mar 2017 — TEAS STATEMENT OF USE RECEIVED
- 24 Jan 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 29 Nov 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Nov 2016 — PUBLISHED FOR OPPOSITION